Matthew Krebs
0000-0001-7540-3064
University of Manchester
3 papers found
Refreshing results…
Ceralasertib (AZD6738), an Oral ATR Kinase Inhibitor, in Combination with Carboplatin in Patients with Advanced Solid Tumors: A Phase I Study
Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or MetastaticROS1Fusion–Positive Non–Small-Cell Lung Cancer
Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study
Missing publications? Search for publications with a matching author name.